🇺🇸 FDA
Drug

bupivacaine

Brand: EXPAREL

approved

Quick answer

bupivacaine (EXPAREL), is a pharmaceutical active ingredient, associated with Pacira BioSciences, with approved status in the US.

Key facts

INN
bupivacaine
Brand
EXPAREL
Route
PERIARTICULAR
Formulation
INJECTABLE, LIPOSOMAL
Originator
Pacira BioSciences

Related patents

patent

US 12370142

Manufacturing of bupivacaine multivesicular liposomes

Expires Mon Jul 24 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12318483

Manufacturing of bupivacaine multivesicular liposomes

Expires Mon May 29 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12296047

Manufacturing of bupivacaine multivesicular liposomes

Expires Mon May 08 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12285419

Bupivacaine multivesicular liposome formulations and uses thereof

Expires Mon Apr 24 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12280149

Manufacturing of bupivacaine multivesicular liposomes

Expires Mon Apr 17 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12251472

Manufacturing of bupivacaine multivesicular liposomes

Expires Mon Mar 13 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12251468

Manufacturing of bupivacaine multivesicular liposomes

Expires Mon Mar 13 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12246092

Manufacturing of bupivacaine multivesicular liposomes

Expires Mon Mar 06 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

Frequently asked questions

What is bupivacaine?

bupivacaine (EXPAREL), is a pharmaceutical active ingredient, associated with Pacira BioSciences, with approved status in the US.

What is the brand name for bupivacaine?

EXPAREL is a marketed brand name for bupivacaine. Check FDA Drugs@FDA for the current US label holder.